Rheumatology Association of Iowa 4th Annual Meeting 2018 (RAI 2018)

//Rheumatology Association of Iowa 4th Annual Meeting 2018 (RAI 2018)

Loading Events
This event has passed.
Rheumatology Association of Iowa

Rheumatology Association of Iowa

The Rheumatology Association of Iowa (RAI) 4th Annual Meeting will be held during Feb 23 – 24, 2018 at The Hotel at Kirkwood Center, Cedar Rapids, Iowa, United States of America.

Registration/Information Desk Hours

Location: Student Common Area
Friday, February 23, 20183:00 p.m. – 7:00 p.m.
Saturday, February 24, 20187:30 a.m. – 4:00 p.m.

Exhibit Hall Hours

Location: Student Common Area
Friday, February 23, 20184:30 p.m. – 7:00 p.m.
Saturday, February 24, 20188:00 a.m. – 3:00 p.m.

Additional Registration Information

Registration Fee Includes:

  • Entrance to all sessions
  • Program Materials
  • Welcome Reception
  • Continental Breakfast / Breaks / Lunch

Special Needs

For accommodations on the basis of disability or special dietary needs, please call (847) 517-7225.

Questions

Contact the RAI Executive Office by:
Phone: (847) 517-7225
Fax: (847) 517-7229
Email: rai@wjweiser.com

EVENT REGISTRATION

Today’s challenging health care environment is affecting the way physicians manage their practices, interfering with access to care and forcing them to make difficult decisions. Physicians seek to continue to provide quality care while contending with reduced Medicare reimbursement rates, medical claims, process errors and inefficiency, and legislative and regulatory changes. Rheumatologists need to be aware of emerging trends in practice management, payer reform, and administrative simplification of impact to the success of their practices and quality of patient care.

Rheumatologists and their patients will be significantly impacted by the implementation of MACRA, thus education and training on the resultant programs are important to ensure practice viability and compliance with the new requirements. Absent such education, rheumatology practices are more likely to absorb steep financial penalties and fail to comply with new statutory and regulatory mandates, which could subsequently result in the closure of rheumatology practices and loss of beneficiary access to important rheumatology care.